OUR BLOG

Discover sickle cell disease stories and updates from SCAGO

News

Our latest post

SCAGO

Apr 8, 2025

Lack of Adequate Information on Insurance Policies Provided to International Students with Chronic Illnesses

Unclear health insurance coverage is a daunting reality for thousands of international students yearly.

Read Article

Articles

Discover our other posts

Explore our articles to know the best behavior about alimentation and well-being.

SCAGO

Apr 8, 2025

Lack of Adequate Information on Insurance Policies Provided to International Students with Chronic Illnesses

Unclear health insurance coverage is a daunting reality for thousands of international students yearly.

SCAGO

Sep 26, 2024

Health Canada Grants Marketing Authorization of First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY®

The Sickle Cell Awareness Group of Ontario (SCAGO) is pleased with the news of CASGEVY (Exagamglogene Autotemcel) receiving marketing authorization for the treatment of Sickle Cell and Thalassemia disorders in Canada.

Sep 27, 2024

Pfizer Voluntarily Withdraws All Lots of Sickle Cell Disease Treatment OXBRYTA® (voxelotor) From Worldwide Markets

Pfizer Inc. announced today that it is voluntarily withdrawing all lots of OXBRYTA ® (voxelotor) for the treatment of sickle cell disease (SCD) at this time, in all markets where it is approved.